Eledon Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$40,326,000 over the previous period. Total operating expenses were $43,000,000.
Profit Margin
| 2014 | 0 | -23.29M | |
|---|---|---|---|
| 2015 | 0 | -45.08M | |
| 2016 | 0 | -37.95M | |
| 2017 | 0 | -13.11M | |
| 2018 | 0 | -14.06M | |
| 2019 | 0 | -17.87M | |
| 2020 | 120K | -22.81M | -19009.17% |
| 2021 | 0 | -34.50M | |
| 2022 | 0 | -87.50M | |
| 2023 | 0 | -40.32M |
ELDN Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 120K | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 374K | 373K | 195K | 183K | 182K | 11K | 22K | 35K | 109K | 58 |
Gross profit | -374K | -373K | -195K | -63K | -182K | -11K | -22K | -35K | -109K | -58 |
Operating exp. | ||||||||||
Research and development | 30.31M | 27.08M | 23.73M | 6.13M | 8.12M | 6.81M | 2.02M | 25.02M | 32.63M | 14.57M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 43M | 39.78M | 36.86M | 16.18M | 14.18M | 14.06M | 13.12M | 38.12M | 45.26M | 23.46M |
Operating income | -43M | 8.49M | -36.86M | -18.46M | -16.05M | -14.06M | -13.12M | -38.12M | -45.26M | -23.46M |
Other income (expenses), net | 2.67M | -96.46M | 7K | -4.75M | 40K | -5K | 5K | 164K | 174K | 166K |
Income before tax | -40.32M | -87.96M | -36.86M | -23.21M | -16.01M | -14.06M | -13.11M | -37.95M | -45.08M | -23.29M |
Income tax expense | 0 | -462K | -2.35M | -404K | 1.86M | -5K | 0 | 0 | 0 | -187K |
Net income | -40.32M | -87.50M | -34.50M | -22.81M | -17.87M | -14.06M | -13.11M | -37.95M | -45.08M | -23.29M |
Earnings per share | ||||||||||
Basic EPS | -0.00 | -6.13 | -2.33 | -15.72 | -27.27 | -28.11 | -50.47 | -1.78K | -324.85 | -583.36 |
Diluted EPS | -1.64 | -6.13 | -2.33 | -15.72 | -27.27 | -28.11 | -50.47 | -1.78K | -324.85 | -583.36 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |